These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10954059)

  • 1. Efficacy, safety and tolerability of combined administration of lithium and selective serotonin reuptake inhibitors: a review of the current evidence. Hertfordshire Neuroscience Research Group.
    Hawley CJ; Loughlin PJ; Quick SJ; Gale TM; Sivakumaran T; Hayes J; McPhee S
    Int Clin Psychopharmacol; 2000 Jul; 15(4):197-206. PubMed ID: 10954059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serotonergic syndrome--in combination therapy with lithium and fluoxetine].
    Karle J; Bjørndal F
    Ugeskr Laeger; 1995 Feb; 157(9):1204-5. PubMed ID: 7701669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Algorithms for the pharmacotherapy of bipolar disorder.
    Motohashi N
    Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S41-4. PubMed ID: 10560897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of paroxetine and amitriptyline as adjunct to lithium maintenance therapy in bipolar depression: a reanalysis of a randomized, double-blind study.
    Pilhatsch M; Wolf R; Winter C; Lewitzka U; Bauer M
    J Affect Disord; 2010 Nov; 126(3):453-7. PubMed ID: 20547424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of the initial drug(s) in the treatment of bipolar disorder, depressed phase.
    Maj M
    Mod Probl Pharmacopsychiatry; 1997; 25():66-77. PubMed ID: 9344370
    [No Abstract]   [Full Text] [Related]  

  • 7. Mood stabilizers and treatment adherence in bipolar disorder: addressing adverse events.
    Berk M; Berk L
    Ann Clin Psychiatry; 2003; 15(3-4):217-24. PubMed ID: 14971867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of atypical antipsychotics in depressive syndromes].
    Quintin P; Thomas P
    Encephale; 2004; 30(6):583-9. PubMed ID: 15738862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.
    Calabrese JR; Bowden CL; Sachs G; Yatham LN; Behnke K; Mehtonen OP; Montgomery P; Ascher J; Paska W; Earl N; DeVeaugh-Geiss J;
    J Clin Psychiatry; 2003 Sep; 64(9):1013-24. PubMed ID: 14628976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower serum levels of lithium may produce efficacy without adverse effects.
    Shim SS
    Am J Geriatr Psychiatry; 2009 Jul; 17(7):625; author reply 625-6. PubMed ID: 19546659
    [No Abstract]   [Full Text] [Related]  

  • 11. Bipolar disorder with Asperger's disorder.
    Duggal HS
    Am J Psychiatry; 2003 Jan; 160(1):184-5. PubMed ID: 12505825
    [No Abstract]   [Full Text] [Related]  

  • 12. Open-label, concomitant use of lamotrigine and other medications for bipolar disorder.
    Bowden CL; Edwards S; Evoniuk G
    CNS Spectr; 2008 Jan; 13(1):75-83. PubMed ID: 18204417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrapyramidal syndrome due to valproate administration as an adjunct to lithium in an elderly manic patient.
    Wils V; Golüke-Willemse G
    Int J Geriatr Psychiatry; 1997 Feb; 12(2):272. PubMed ID: 9097225
    [No Abstract]   [Full Text] [Related]  

  • 14. Predictors of efficacy in lithium augmentation for treatment-resistant depression.
    Sugawara H; Sakamoto K; Harada T; Ishigooka J
    J Affect Disord; 2010 Sep; 125(1-3):165-8. PubMed ID: 20089312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.
    van der Loos ML; Mulder PG; Hartong EG; Blom MB; Vergouwen AC; de Keyzer HJ; Notten PJ; Luteijn ML; Timmermans MA; Vieta E; Nolen WA;
    J Clin Psychiatry; 2009 Feb; 70(2):223-31. PubMed ID: 19200421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebellar ataxia in upper limbs triggered by addition of carbamazepine to lithium treatment.
    Manto MU; Jacquy J; Hildebrand J
    Acta Neurol Belg; 1996 Dec; 96(4):316-7. PubMed ID: 9008782
    [No Abstract]   [Full Text] [Related]  

  • 17. L-thyroxine augmentation of serotonergic antidepressants in female patients with refractory depression.
    Łojko D; Rybakowski JK
    J Affect Disord; 2007 Nov; 103(1-3):253-6. PubMed ID: 17289154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of initial treatment for bipolar disorder, manic phase.
    Frye MA; Altshuler LL
    Mod Probl Pharmacopsychiatry; 1997; 25():88-113. PubMed ID: 9344372
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety and tolerability of dexmecamylamine (TC-5214) adjunct to ongoing antidepressant therapy in patients with major depressive disorder and an inadequate response to antidepressant therapy: results of a long-term study.
    Tummala R; Desai D; Szamosi J; Wilson E; Hosford D; Dunbar G; Eriksson H
    J Clin Psychopharmacol; 2015 Feb; 35(1):77-81. PubMed ID: 25514064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.
    Tohen M; Chengappa KN; Suppes T; Zarate CA; Calabrese JR; Bowden CL; Sachs GS; Kupfer DJ; Baker RW; Risser RC; Keeter EL; Feldman PD; Tollefson GD; Breier A
    Arch Gen Psychiatry; 2002 Jan; 59(1):62-9. PubMed ID: 11779284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.